RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension …

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension …

Add to Collection
RCTs MR McClung, ML O'Donoghue… - The lancet Diabetes & …, 2019 - thelancet.com

Chapter : Section2
Journal Year : 2019
Cited by : 116

… After a median follow-up of 36·5 months (IQR 34·43–40·15) 4297 women assigned to odanacatib and 3960 assigned to placebo enrolled in LOFT Extension (total median follow-up 47·6 …..... Read More

Keywords : ['loft multicentre randomise doubleblind placebocontrolle trial', 'postmenopausal osteoporosis result', 'loft extension', 'treatment', 'odanacatib']
PubMed Link : https://www.thelancet.com/journals/landia/article/PIIS2213-8587(19)30346-8/fulltext
Google Scholar Link : https://scholar.google.com/scholar?cites=5124438460329321642&as_sdt=2005&sciodt=0,5&hl=en&num=20